[Rod-derived cone viability factor: a clue for therapy of retinitis pigmentosa?].
Léveillard
Thierry
T
Mohand-Saïd
Saddek
S
Poch
Olivier
O
Sahel
José-Alain
JA
D000818:Animals; D006801:Humans; D012174:Retinitis Pigmentosa / Q000628:therapy*; D013879:Thioredoxins
C488098:NXNL1 protein, human; D013879:Thioredoxins